Explained: How do scientists generate bispecific antibodies?

As bispecific antibodies emerge as therapeutic game changers, scientists leverage cutting-edge technologies to navigate their multifaceted development.

By simultaneously targeting two different antigens, bispecific antibodies engage biological pathways and precisely direct the immune system to disease targets, enabling more effective treatments. Yet, the journey from discovery to clinical application requires careful structural design and thorough functional and developability assessment.

Download this Explainer Article from Cytiva to learn about designing, screening, and characterizing bispecific antibodies. 

Sponsored by